About SpiroFriend
SpiroFriend is a company based in Denmark founded in 2015. It operates as a D2C. SpiroFriend offers products and services including IPPI. SpiroFriend operates in a competitive market with competitors including Circassia Pharmaceuticals and Aerocrine, among others.
- Headquarter Denmark
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Spirofriend Aid Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SpiroFriend
SpiroFriend offers a comprehensive portfolio of products and services, including IPPI.
Portable tool for analyzing exhaled gases and lung function in asthmatic patients.
Funding Insights of SpiroFriend
Detailed funding history for SpiroFriend
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SpiroFriend
Investment portfolio details for SpiroFriend
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SpiroFriend
Detailed financials for SpiroFriend
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spirofriend Comparisons
Peer comparison for SpiroFriend
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SpiroFriend
SpiroFriend operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Circassia Pharmaceuticals and Aerocrine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Treatments for asthma, COPD, and allergies are developed by Circassia.
|
|
| Locked | Locked | Locked |
Point-of-care devices for airway inflammation measurement are developed.
|
Detailed competitors of SpiroFriend
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spirofriend
Complete news archive for SpiroFriend
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SpiroFriend
SpiroFriend was founded in 2015.
SpiroFriend is headquartered in Denmark.
SpiroFriend is a med-tech company that creates innovative products using AI and nanotechnology, focusing on lung diagnostics. Their main offering, the Intelligent Personal Portable Inflammometer (IPPI), measures exhaled gases like fractional exhaled Nitrogen Oxide for asthmatic patients. Developed over 10 years, it aims to provide affordable tools that improve quality of life and support respiratory research. The company holds patents for market advantages and plans expansions for other pulmonary diseases, based in Denmark.
SpiroFriend's top competitors include Circassia Pharmaceuticals and Aerocrine.
SpiroFriend offers IPPI.